IPS HEART
CA - San DiegoBiotechnology
Focus: IPS HEART is a San Diego-based biotechnology company specializing in induced pluripotent stem cell (iPSC) cardiac therapies, focused on regenerative treatment of cardiovascular disease. As a public-stage biotech founded in 2014, the company operates in the emerging cell therapy space with a narrow therapeutic focus.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at IPS HEART?
AI assessmentIPS HEART offers scientifically interesting cell therapy exposure but presents significant uncertainty around clinical progress, organizational growth, and financial stability—suitable only for risk-tolerant candidates with deep iPSC interest.
Why Work Here
- Opportunity to contribute to cutting-edge iPSC technology in a high-impact therapeutic area (cardiovascular disease) with significant unmet medical need.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (1)
Interview Prep Quick Facts
Founded:
Help build intelligence for IPS HEART
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.